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Abstract Up-front cholecystectomy is the recommended therapy for acute cholecystitis (AC). However, the scientific
basis for the definition of the optimal timing for surgery is scarce. The aim of this study was to analyze how the timing
of surgery, after the admission to hospital for AC, affects the intra- and postoperative outcomes. Within the national
Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks), all patients
undergoing cholecystectomy for acute cholecystitis between January 2006 and December 2014 were identified. Data
regarding patient characteristics, intra- and postoperative adverse events (AEs), bile duct injuries, and 30- and 90-day
mortality risk were captured, and the correlation between the surgical timing and these parameters was analyzed. In total,
data on 87,108 cholecystectomies were analyzed of which 15,760 (18.1 %) were performed due to AC. Bile duct injury,
30- and 90-day mortality risk, and intra- and postoperative AEs were significantly higher if the time from admission to
surgery exceeded 4 days. The time course between surgery and complication risks seemed to be optimal if surgery was
done within 2 days after hospital admission. Although AC patients operated on the day of hospital admission had a
slightly increased AE rate as well as 30- and 90-day mortality rates than those operated during the interval of 1–2 days
after admission, the bile duct injury and conversion rates were, in fact, significantly lower. The optimal timing of
cholecystectomy for patients with AC seems to be within 2 days after admission. However, the somewhat higher
frequency of AE on admission day may emphasize the importance of optimizing the patient before surgery as well as
ensuring that adequate surgical resources are available.
Keywords Acute cholecystitis . Laparoscopic
cholecystectomy . Open cholecystectomy . Admission day .
Adverse events . Bile duct injury
Introduction
Cholecystectomy has since long been the therapy of choice for
elective treatment of patients with symptomatic gallstone dis-
ease. Acute cholecystitis (AC) is a well-known complication
of gallbladder stone disease. Over the years, it has been
claimed that AC can be primarily treated conservatively and
then followed by delayed elective cholecystectomy. In recent
decades, evidence has been gathered to show that early cho-
lecystectomy for AC during the acute hospital stay is safe and
cost-effective.1–11 Lately, data have emerged from centers
with great experience in laparoscopic surgery to show that
early laparoscopic cholecystectomy is an attractive, feasible,
and safe therapeutic strategy.12–14 Recent meta-analyses con-
cluded that early laparoscopic cholecystectomy appears to be
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were also reached in a current Cochrane systemic review.18 A
recent multicenter (n = 35 centers) randomized trial (n = 618
patients), studying early versus delayed cholecystectomy, fi-
nally settled the issue showing that laparoscopic cholecystec-
tomy, when performed within 24 h of hospital admission, was
significantly better as compared to conservative treatment re-
garding both morbidity and costs.13 Another controversial
topic is the optimal timing of surgery in AC, where one of
the issues is whether it should be operated early (i.e., within
the first 48 to 96 h) or delayed (within the same hospital stay),
depending on the actual practical and logistic circumstances.
Studies, incorporating a limited number of patients, have in-
dicated that the best time window to operate AC might be
within the first 48 to 96 h.5,8 A French nationwide registry
study has recently shown that operation within 3 days after
admission is recommended in patients with acute cholecysti-
tis.19 To address a similar question within an RCT, it would
require a large number of patients to create sufficient power
for testing the hypotheses, which basically preclude the com-
pletion of trials within reasonable time limits. National quality
registry studies can act as a complement to RCTs. Registries
enable data collection on large-scale patient cohorts, permit-
ting analyses with good statistical power. Corresponding reg-
istry studies have been able to address clinical questions that,
due to statistical, time, and financial constraints, would never
have been studied in RCTs, for example the value of intraop-
erative cholangiography in preventing bile duct injury in gall-
stone surgery.20–21 The aim of this study was therefore to
compare the outcomes for patients operated on for AC in the
entire country, during a 9-year period, with particular focus on
the time elapsed from admission to hospital until the chole-
cystectomy was carried out, and the impact of these time pe-
riods on the intra- and postoperative adverse events.
Methods
Swedish Registry of Gallstone Surgery and Endoscopic
Retrograde Cholangiopancreatography (GallRiks)
The Swedish Registry of Gallstone Surgery and Endoscopic
Retrograde Cholangiopancreatography (ERCP) was founded
on May 2005 by the Swedish National Board of Health and
Welfare, the Swedish Surgical Association, and the Swedish
Society of Laparoscopic Surgery. It is financially supported by
the Swedish national health authorities. On an annual basis,
approximately 20,000 procedures (12,000 cholecystectomies
and 8000 ERCPs) are registered. The aim of the registry is to
obtain continuously updated information regarding indica-
tions, outcomes, and patient satisfaction in order to ensure
high-quality care of patients needing cholecystectomy, regard-
less of where in Sweden they are managed.22 The operating
surgeon registers the procedure online, preferably during the
operation or immediately after. A 30-day follow-up is admin-
istered by the local coordinator at each participating hospital.
The follow-up is also registered online. The validity of data is
monitored by independent reviewers, who visit the participat-
ing hospitals at least once every third year and compare the
online registrations with the corresponding patient records.
The validation of GallRiks has demonstrated high correctness
and completeness of data and no failure to report serious ad-
verse events.23 The registry attained an overall national cov-
erage of approximately 90 % during the actual enrolment
period.
Study Design
We conducted a nationwide, population-based, nested case-
control study within the cohort of cholecystectomies entered
into GallRiks between 1 January 2006 and 31 December
2014. Index cholecystectomies with a complete 30-day fol-
low-up were identified. From this cohort, procedures per-
formed with the indications of malignancy, concomitant major
surgery in conjunction with cholecystectomy, as well as acute
pancreatitis were excluded, leaving 87,108 cholecystectomies
for analysis (Fig. 1).
Fig. 1 The procedures included in the analysis
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Definitions
For the purpose of this paper and in accordance with the de-
scriptions in the GallRiks database, the following definitions
were applied.
Intraoperative adverse events are defined as bleeding,
bile duct injury, gut perforation, or any other reason for
the cholecystectomy to be terminated prematurely.
Intraoperative bleeding demanding intervention is de-
fined as any bleeding requiring blood transfusion or con-
version to open surgery. Bleeding that is controlled
completely with diathermy, clips, or sutures is not con-
sidered to be intraoperative bleeding demanding an inter-
vention. Data are not filed on the volume of blood loss
and number of transfused blood units.
Bile duct injury (BDI) is defined as intraoperatively reg-
istered (a) BDI ≤1/3 of the diameter, (b) BDI >1/3 of the
diameter, (c) resection of a substantial part of the bile duct
wall, or (d) complete transection of the bile duct.
Postoperative adverse events are defined as any compli-
cation during the 30-day follow-up period that required
some form of medical or surgical intervention.
Statistics
Statistical analysis was performed using JMP 12.1.0 (64-bit)
(SAS Institute, Inc., Cary, NC, USA). Comparisons of patient-
and procedure-related characteristics were presented in con-
tingency tables, with pairwise differences analyzed with
Pearson’s chi-square test and presented as P values. The asso-
ciation between acute cholecystitis and the time of operation
after admission as well as the risk of adverse events and mor-
tality were analyzed using multivariable logistic regression
modeling. Variables that were statistically significant in uni-
variate analysis were included in the multivariate model as
described by Hosmer et al.24
In the multivariate analysis, the outcome was adjusted for
age (dichotomized into more or less than 50 years), gender,
comorbidity (dichotomized into ASA 1–2 and ASA ≥3), acute
or scheduled surgery, indication for and type of surgery, as
well as if the patients had a history of previous acute
cholecystitis.
The models were tested for multicollinearity and effect
modification and finally assessed for goodness of fit. The ef-
fects of analyzed variables were presented as odds ratios
(ORs) for adverse events with 95 % confidence intervals.
Ethical considerations
The regional research ethics committee at Karolinska
Institutet, Stockholm, Sweden, approved the study.
Results
Between 1 January 2006 and 31 December 2014, 100,258
cholecystectomies were registered in GallRiks of which
87,108 met the inclusion criteria (Fig. 1). The demographics
of the study population, the surgical technique for the chole-
cystectomy, antibiotic use, and length of hospital stay for pa-
tients with or without AC are given in Table 1. For all outcome
measures given, except for the length of postoperative hospital
stay after open cholecystectomy, the two groups (AC versus
no AC) differed significantly. In the AC group, there was a
significantly increased risk of intra- and postoperative adverse
events (Table 2). Neither the 30- nor the 90-day mortality risk,
however, differed significantly in the multivariate analysis
(Table 2). In the subgroup of patients operated on with chole-
cystectomy (laparoscopic or open) for AC, the majority had an
operation during the first day after admission (39.2 %) follow-
ed by those who had an operation on the second day (27.3 %).
Cholecystectomy on the admission day was performed in
11.9 % of the AC patients (Fig. 2). The conversion rate in
the latter group increased in a stepwise manner from 16.6 %
on admission day to 27.8 % on >4 days after admission
(Fig. 2). The multivariate analysis of the AC patients, with
regard to the risk of intraoperative adverse events, revealed a
significantly lower risk for adverse event (AE) when the op-
eration was done on the first or second day after admission
(Table 3). The risk of intraoperatively detected bile duct inju-
ries was, however, lowest when the cholecystectomy was
done on the day of admission with a thereafter day-by-day
stepwise increased risk (Table 3). The risk of postoperative
AEwas significantly lower in patients operated within the first
4 days after admission as compared to those operated 5 days
or more after admission (Table 3). The 30-day mortality risk
was significantly lower when operated during the first day
after admission, and even the 90-day mortality risk was sig-
nificantly reduced if the operation was completed within
3 days of admission as compared to those operated 5 days or
more thereafter (Table 3). Intraoperative blood loss was not
affected by the time elapsed from admission.
Discussion
This study represents one of the largest patient cohorts ad-
dressing the correlation between the time elapsed from hospi-
tal admission for AC and definitive surgery and the risk for
intra- and postoperative AE. We found that the optimal time
slot for surgery was within the first 2 days after hospital ad-
mission. Cholecystectomy on admission day was performed
in close to 12 % of the AC patients, and the risk of intraoper-
atively detected bile duct injuries was lowest when the chole-
cystectomywas done on the day of admission with a thereafter
day-by-day stepwise increase. These findings support the
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findings in the literature of the beneficial effect of early sur-
gery on AC.5,8,19 This information is clinically relevant since
the majority of minor bile duct lesions are detected intraoper-
atively and repair is usually attempted at the index procedure
Table 1 Demographics of acute
cholecystitis (AC) and no AC AC (n = 15,760) No AC (n = 71,348) P
n % n %
Gender
Females 8376 53.15 50,526 70.82 <0.0001
Males 7384 46.85 20,822 29.18
Age (years)a
>50 9731 61.97 33,073 46.42 <0.0001
≤50 5971 38.03 38,169 53.58
ASA
1–2 13,792 87.51 66,965 93.86 <0.0001
≥3 1968 12.49 4383 6.14
Op technique
LC (Op started with laparoscopic technique) 12,522 79.45 68,803 96.43 <0.0001
Convertedb 2520 20.12 3622 5.26 <0.0001
Antibiotics
Prophylactic 4531 28.75 11,859 16.62 <0.0001
Treatment 7963 50.53 3002 4.21
No antibiotics 3266 20.72 56,487 79.17
Hospital stay (days)c Mean SEM Mean SEM
Length of postop stay 3.52 0.04 1.59 0.01 <0.0001
LC postop stay 2.98 0.04 1.43 0.01 <0.0001
OC postop stay 5.60 0.11 5.69 0.15 0.5988
aMissing 164
b Excluded 5783 OCs
cMissing 85
Table 2 Risk of intra- and postoperative adverse events (AEs) in acute cholecystitis (AC) and no AC, respectively
Number Percent Univariate Multivariatea
AE No AE OR (95 % CI) P OR (95 % CI) P
Intraop AE
No AC 2028 69,320 2.84 1.0 (reference) 1.0 (reference)
AC 618 15,142 3.92 1.40 (1.27–1.53) <0.0001 1.23 (1.12–1.35) <0.0001
Intraop bleeding
No AC 496 70,852 0.70 1.0 (reference) 1.0 (reference)
AC 234 15,526 1.48 2.15 (1.84–2.51) <0.0001 1.54 (1.30–1.82) <0.0001
Intraop bile duct injury
No AC 201 71,147 0.28 1.0 (reference) 1.0 (reference)
AC 67 15,693 0.43 1.51 (1.14–1.98) 0.0048 1.44 (1.08–1.90) 0.0137
Postop AE
No AC 5250 66,098 7.36 1.0 (reference) 1.0 (reference)
AC 1896 13,864 12.03 1.72 (1.63–1.82) <0.0001 1.38 (1.26–1.51) <0.0001
Mortality (≤30 days)
No AC 47 71,301 0.07 1.0 (reference) 1.0 (reference)
AC 73 15,687 0.46 7.06 (4.91–10.25) <0.0001 1.25 (0.67–2.22) 0.4720
Mortality (≤90 days)
No AC 100 71,248 0.14 1.0 (reference) 1.0 (reference)
AC 129 15,631 0.82 5.88 (4.53–7.65) <0.0001 1.04 (0.72–1.49) 0.8137
a Adjusted for sex, age, ASA, acute/scheduled surgery, indication, type of surgery, and previous acute cholecystitis
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with satisfactory results,25 an observation which is not entirely
consistent with the international experiences.20,21 However, in
the multivariate analysis, we observed a significantly lower risk
for AE when the operation was done on the first or second day
after admission. These differences in morbidity were also trans-
lated into 30-day mortality risk, which were significantly lower
when the cholecystectomy was completed during the first day
after admission. Even the 90-daymortality risk was significantly
reduced for those operated within 3 days of admission.
Although operation on admission day in most of our assess-
ments has a significantly better outcome than in those being
operated 5 days or more after admission, the frequency of ad-
verse events was somewhat higher compared to an operation
performed 1 or 2 days thereafter. The reason for these findings
may be found in the fact that some patients arrive at the emer-
gency unit in a bad general condition where time is required for
resuscitation and stabilization of the patient, before embarking
on definitive surgery. Furthermore, if the patient with acute cho-
lecystitis arrives at the hospital during non-office hours and is
immediately scheduled for cholecystectomy, the issue of not
being able to offer the highest level of laparoscopic surgical
expertise may have a bearing on the outcome. Nevertheless,
these issues did not translate into an enhanced risk for BDI.
In a similar analysis of 4113 prospective cholecystectomies
performed on patients with acute cholecystitis as reported from
the Swiss Association of Laparoscopic and Thoracoscopic
Surgery (SALTS) database, the authors concluded that imme-
diate surgery (surgery on the day of admission or at the latest
within 24 h of admission) significantly reduced the risk of con-
version from laparoscopic to open surgery, which can be used
as a proxy variable for the safety and accuracy of the respective
operations.12 This is to some extent in line with our study,
where the conversion rate, when operation occurred on admis-
sion day, was 16.6 % and then increased in a linear fashion to
27.8 % in patients operated on 4 days later. However, whereas
the technical conditions for surgery may be optimal on
admission day, due to less extent of the inflammation, the find-
ings in our study of a better outcome when patients are operated
on the first or second day after admission may indicate that
other factors, like the general condition of the patient, mandate
attention in order to optimize the outcome.
Studies on the management of patients with AC in routine
surgical practice have revealed that basically, no major changes
have occurred over recent years.14,26,27 This illustrates the prob-
lems and challenges in the implementation of evidence-based
guidelines for the treatment of AC. To some extent, this may be
explained by a larger proportion of elderly patients with high
comorbidity; however, one cannot rule out a widespread con-
servative attitude with resistance to new evidence-based ap-
proaches.26 The slow adaptation to new guidelines could have
several other explanations such as local logistic problems and
lack of resources for acute surgery. There may also be a pro-
portion of patients with a long duration of symptoms before
seeking medical attention, resulting in reluctance to an emer-
gency operation.
The strengths of the current analyses are represented by the
magnitude of the database, extracted from the national Swedish
Registry of Gallstone Surgery and ERCP (GallRiks), which
describes the outcome of cholecystectomies performed at near-
ly all hospitals in Sweden in routine clinical practice. Thus,
regional differences, as well as differences in catchment areas
and profiles of the hospitals, can be compensated for. An addi-
tional strength of the study is that the data are registered pro-
spectively by the respective surgeons, online, at the time of
completion of the operation.
We also recognize that there are some obvious limita-
tions of the study. GallRiks is a national quality register
for gallstone surgery and ERCP, and accordingly, the
quality and relevance of some clinical data can rightfully
be questioned since these are not entered into the registry
as a part of a randomized controlled trial protocol with the
specific, dedicated aim of addressing specific questions. A
Fig. 2 Acute cholecystitis (AC).
Adverse events in relation to the
time of surgery after admission
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Table 3 Risk of adverse events (AEs) in acute cholecystitis in relation to the timing of surgery after admission to hospital
Time between admission
and treatment (days)
Number (n = 15,189a) Univariate Multivariatea
Yes No % OR (95 % CI) P OR (95 % CI) P
Intraoperative AE
≥5 44 709 5.84 1.0 (reference) 1.0 (reference)
4 37 718 4.90 0.83 (0.53–1.30) 0.4166 0.88 (0.56–1.38) 0.5819
3 78 1703 4.38 0.74 (0.51–1.09) 0.1221 0.81 (0.55–1.19) 0.2811
2 146 3997 3.52 0.59 (0.42–0.84) 0.0041 0.66 (0.47–0.95) 0.0261
1 212 5745 3.56 0.59 (0.43–0.84) 0.0038 0.67 (0.49–0.96) 0.0285
Admission day 71 1729 3.94 0.66 (0.45–0.98) 0.0393 0.74 (0.50–1.10) 0.1377
Intraoperative bleeding
≥5 15 738 1.99 1.0 (reference) 1.0 (reference)
4 15 740 1.99 1.00 (0.48–2.07) 0.9941 1.14 (0.55–2.38) 0.7254
3 29 1752 1.63 0.81 (0.44–1.57) 0.5271 0.97 (0.52–1.88) 0.9187
2 61 4082 1.47 0.74 (0.43–1.35) 0.3052 0.94 (0.54–1.73) 0.8347
1 80 5877 1.34 0.67 (0.40–1.21) 0.1771 0.86 (0.50–1.57) 0.6054
Admission day 28 1772 1.56 0.78 (0.42–1.50) 0.4417 0.97 (0.52–1.88) 0.9255
Bile duct injury intraoperatively
≥5 7 746 0.93 1.0 (reference) 1.0 (reference)
4 4 751 0.53 0.57 (0.15–1.89) 0.3586 0.59 (0.15–1.97) 0.3950
3 12 1769 0.67 0.72 (0.29–1.95) 0.5037 0.78 (0.31–2.11) 0.6106
2 16 4127 0.39 0.41 (0.18–1.08) 0.0691 0.45 (0.19–1.18) 0.1007
1 22 5935 0.37 0.40 (0.18–1.00) 0.0505 0.43 (0.19–1.11) 0.0780
Admission day 3 1797 0.17 0.18 (0.04–0.64) 0.0081 0.19 (0.04–0.68) 0.0107
Postoperative AE
≥5 130 623 17.26 1.0 (reference) 1.0 (reference)
4 80 675 10.60 0.57 (0.42–0.76) 0.0002 0.61 (0.45–0.82) 0.0012
3 209 1572 11.73 0.64 (0.50–0.81) 0.0002 0.71 (0.56–0.90) 0.0055
2 480 3663 11.59 0.63 (0.51–0.78) <0.0001 0.72 (0.58–0.90) 0.0041
1 700 5257 11.75 0.64 (0.52–0.79) <0.0001 0.73 (0.60–0.91) 0.0044
Admission day 227 1573 12.61 0.69 (0.55–0.88) 0.0024 0.78 (0.62–1.00) 0.0468
Mortality (≤30 days)
≥5 10 743 1.33 1.0 (reference) 1.0 (reference)
4 10 745 1.32 1.00 (0.41–2.44) 0.9952 1.36 (0.54–3.43) 0.5030
3 8 1773 0.45 0.34 (0.13–0.85) 0.0223 0.49 (0.18–1.28) 0.1465
2 16 4127 0.39 0.29 (0.13–0.66) 0.0042 0.52 (0.23–1.21) 0.1245
1 18 5939 0.30 0.23 (0.11–0.51) 0.0007 0.40 (0.18–0.93) 0.0344
Admission day 10 1790 0.56 0.42 (0.17–1.02) 0.0539 0.62 (0.25–1.56) 0.3096
Mortality (≤90 days)
≥5 22 731 2.92 1.0 (reference) 1.0 (reference)
4 13 742 1.72 0.58 (0.28–1.15) 0.1198 0.77 (0.37–1.57) 0.4794
3 15 1766 0.84 0.28 (0.14–0.54) 0.0002 0.40 (0.20–0.79) 0.0085
2 30 4113 0.72 0.24 (0.14–0.43) <0.0001 0.42 (0.24–0.76) 0.0048
1 29 5928 0.49 0.16 (0.09–0.29) <0.0001 0.28 (0.16–0.51) <0.0001
Admission day 17 1783 0.94 0.32 (0.16–0.60) 0.0004 0.47 (0.24–0.91) 0.0253
In 571 of the 15,760, LOS was not correctly stated. Values in bold-italic are statistically significant (P<0.05). Values in italic are not statistically
significant but indicate a trend
a Adjusted for sex, age, ASA, type of surgery, and previous acute cholecystitis
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further limitation of the register relates to the definition of the
variable postoperative adverse event. Although AEs are de-
fined in the Web protocol, these can be interpreted differently
by the local coordinators at the participating hospitals. In order
to minimize this risk, a list of the most common postoperative
adverse events like pancreatitis, cholangitis, bile leakage, and
deep venous thrombosis, just to mention a few, will from
August 2016 and onwards be visible as predefined options
to the local coordinator as an aid to minimize the interobserver
variability. However, for the data presented in this study, the
coordinator had to decide first whether a postoperative ad-
verse event prevailed before the respective alternatives were
chosen. Another possible limitation of these data is a possible
risk of selection bias where the reporting surgeon may avoid
reporting on negative adverse events related to the surgical
intervention. To avoid this, special attention has been directed
towards corresponding issues, in order to minimize loss of
data quality. An independent coordinator at each participating
hospital reviews each individual intervention and reports on
imbalances at a compulsory 30-day follow-up. The GallRiks
board also undertakes regular validation visits to all the par-
ticipating hospitals, in order to ensure the accuracy and valid-
ity of the registered data. In order to adjust for the possible
skewness of data and other confounding factors such as gen-
der, age, comorbidity (American Society of Anesthesiologists
classification scale), emergent or scheduled surgery, indica-
tion for and type of surgery, as well as a history of previous
acute cholecystitis, these were managed through the multivar-
iate analysis. It needs to be pointed out that the time elapsed
from admission to the operation was only possible to calculate
according to the final date of surgery by the date of admission.
Accordingly, the exact time in hours between operation and
surgery could not be captured. Likewise, the exact time from
onset of symptoms of acute cholecystitis to admission is not
registered in GallRiks. Finally, it must be emphasized that
GallRiks is designed with the Swedish Health Care System
in mind and that the findings in this study must be interpreted
cautiously from an international perspective. Accordingly
some aspects on the current problem related to the manage-
ment of AC can, due to methodological limitations, only be
addressed by indirect measures.
Conclusion
The optimal timing of cholecystectomy for patients with acute
cholecystitis appears to be within the first 2 days of hospital
admission. However, the somewhat higher frequency of ad-
verse events after operations performed on the admission day
emphasizes the importance of optimizing the patient before
surgery as well as ensuring that the highest surgical resources
are available at the time of operation.
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